An outbreak of coronavirus disease 2019 (COVID-19) among passengers and crew on a cruise ship led to quarantine of approximately 3,700 passengers and crew that began on February 3, 2020, and lasted for nearly 4 weeks at the Port of Yokohama, Japan (1). By February 9, 20 cases had occurred among the ship’s crew members. By the end of quarantine, approximately 700 cases of COVID-19 had been laboratory-confirmed among passengers and crew. This report describes findings from the initial phase of the cruise ship investigation into COVID-19 cases among crew members during February 4–12, 2020.

On February 1, a laboratory-confirmed case of COVID-19 was identified in a passenger who had developed symptoms on January 23 and disembarked on January 25, before the ship arrived in Yokohama. Another passenger with a laboratory-confirmed case of COVID-19 had developed symptoms on January 22 and was on the ship when it arrived in Yokohama on February 3. All symptomatic passengers were tested upon arrival in Yokohama, and those with positive results were disembarked February 4 and 5. The index patient for this outbreak could not be determined. On February 5, passengers remaining on the ship were requested to observe 14-day quarantine in their cabins. Approximately two thirds of the persons on board were passengers staying in cabins located on decks 5–12. The remainder (N = 1,068) were crew members, >80% of whose cabins were on decks 2–4. Crew members remained on board the ship at all times and had not disembarked during port calls. After quarantine began, crew members continued to perform their regular duties, delivered meals to passengers, and remained in their cabins when they were not working; symptomatic crew members were required to remain in their cabins.

Because the first detected cases occurred among passengers who became symptomatic on January 22 and 23, COVID-19 was likely transmitted first from passengers to crew members and subsequently spread among the crew, especially among food service workers. The first case detected in a crew member occurred in a food service worker who developed fever on February 2. A real-time polymerase chain reaction test performed by the Yokohama quarantine office laboratory was positive for SARS-CoV-2, the etiologic agent of COVID-19, and the crew member was permitted to disembark in Yokohama on February 4. By February 9, a total of 20 cases* among crew members had been laboratory-confirmed, including three in those who reported close contact with other crew members with laboratory-confirmed COVID-19 before implementation of quarantine. Seven ill crew members had symptom onset within 3 days of the start of quarantine, indicating that some SARS-CoV-2 transmission likely occurred before the implementation of quarantine.

The crew dining area was identified as the primary area of congregation for the crew; passengers did not have access to this part of the ship. The earliest laboratory-confirmed COVID-19 cases in crew members occurred in food service workers; 15 of the 20 confirmed cases in crew members occurred among food service workers who prepared food for other crew members and passengers, and 16 of the 20 cases occurred among persons with cabins on deck 3, the deck on which the food service workers lived (Table). Until February 6, no mechanism for systematic testing was implemented; only crew members who visited the medical clinic with symptoms were tested, and information on the total number of tests administered is not available.
The cruise ship company administered a questionnaire to all crew members on February 3, at which time three crew members reported subjective fever. A second survey of crew members was conducted on February 9, at which time fever was reported by 31 crew members, 20 (65%) of whom were food service workers.

Interviews were conducted with nine crew members with confirmed COVID-19 on February 12, just before their disembarkation; three of these patients reported close contact with other crew members with confirmed COVID-19 before their symptoms began. These interviews indicated that infection had apparently spread among persons whose cabins were on the same deck (deck 3) and who worked in the same occupational group (food service), probably through contact or droplet spread, which is consistent with current understanding of COVID-19 transmission (2). Eight of 20 crew members with confirmed COVID-19 had cabin mates; investigators later learned that following disembarkation, as of March 4, five of the eight cabin mates had also developed COVID-19.

This investigation underscores the need for swift epidemiologic investigation as soon as a COVID-19 case is detected in an area or group where a large number of persons gather in a closed or crowded setting (e.g., a cruise ship, music club, health care setting, sports arena, or gymnasium). These settings have been previously associated with infections spread by contact or droplet, such as influenza (3). Close contacts of persons with confirmed COVID-19 should self-quarantine and monitor their symptoms; persons who develop COVID-19 symptoms while on board a ship should be isolated to limit transmission to other passengers and crew.^†

¹Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo, Japan; ²Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan; ³National Institute of Infectious Diseases, Tokyo, Japan.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.